Your browser doesn't support javascript.
loading
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections.
Granata, Guido; Petrosillo, Nicola; Adamoli, Lucia; Bartoletti, Michele; Bartoloni, Alessandro; Basile, Gregorio; Bassetti, Matteo; Bonfanti, Paolo; Borromeo, Raffaella; Ceccarelli, Giancarlo; De Luca, Anna Maria; Di Bella, Stefano; Fossati, Sara; Franceschini, Erica; Gentile, Ivan; Giacobbe, Daniele Roberto; Giacometti, Enrica; Ingrassia, Fabrizio; Lagi, Filippo; Lobreglio, Giambattista; Lombardi, Andrea; Lupo, Laura Isabella; Luzzati, Roberto; Maraolo, Alberto Enrico; Mikulska, Malgorzata; Mondelli, Mario Umberto; Mularoni, Alessandra; Mussini, Cristina; Oliva, Alessandra; Pandolfo, Alessandro; Rogati, Carlotta; Trapani, Filippo Fabio; Venditti, Mario; Viale, Pierluigi; Caraffa, Emanuela; Cataldo, Maria Adriana.
Afiliação
  • Granata G; Clinical and Research Department for Infectious Diseases, National Institute for Infectious Diseases L. Spallanzani IRCCS, 00149 Rome, Italy.
  • Petrosillo N; Clinical and Research Department for Infectious Diseases, National Institute for Infectious Diseases L. Spallanzani IRCCS, 00149 Rome, Italy.
  • Adamoli L; Infectious Diseases ISMETT IRCCS, 90127 Palermo, Italy.
  • Bartoletti M; Department of Medical and Surgical Sciences, "Alma Mater Studiorum", IRCCS S. Orsola Teaching Hospital, University of Bologna, 40126 Bologna, Italy.
  • Bartoloni A; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
  • Basile G; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
  • Bassetti M; Department of Health Sciences (DISSAL), University of Genoa, 16126 Genoa, Italy.
  • Bonfanti P; Infectious Diseases Unit, San Martino Polyclinic Hospital-IRCCS, 16132 Genoa, Italy.
  • Borromeo R; Infectious Diseases Clinic, Department of Medicine University of Udine and Azienda Sanitaria Universitaria Integrata di Udine, 33100 Udine, Italy.
  • Ceccarelli G; Department of Infectious Diseases, San Gerardo Hospital, Monza-University of Milano-Bicocca, 20126 Milan, Italy.
  • De Luca AM; Hospital of Crema, 26013 Crema, Italy.
  • Di Bella S; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Policlinico Umberto I, 00185 Rome, Italy.
  • Fossati S; Infectious Diseases ISMETT IRCCS, 90127 Palermo, Italy.
  • Franceschini E; Infectious Diseases Department, Azienda Sanitaria Universitaria Integrata di Trieste, 34128 Trieste, Italy.
  • Gentile I; Infectious Diseases Department, Azienda Sanitaria Universitaria Integrata di Trieste, 34128 Trieste, Italy.
  • Giacobbe DR; Clinic of Infectious Diseases, University of Modena and Reggio Emilia, 41121 Modena, Italy.
  • Giacometti E; Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.
  • Ingrassia F; Department of Health Sciences (DISSAL), University of Genoa, 16126 Genoa, Italy.
  • Lagi F; Infectious Diseases Unit, San Martino Polyclinic Hospital-IRCCS, 16132 Genoa, Italy.
  • Lobreglio G; Infectious Diseases Clinic, Department of Medicine University of Udine and Azienda Sanitaria Universitaria Integrata di Udine, 33100 Udine, Italy.
  • Lombardi A; Hospital of Crema, 26013 Crema, Italy.
  • Lupo LI; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
  • Luzzati R; Vito Fazzi Hospital, 73100 Lecce, Italy.
  • Maraolo AE; Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Mikulska M; Vito Fazzi Hospital, 73100 Lecce, Italy.
  • Mondelli MU; Infectious Diseases Department, Azienda Sanitaria Universitaria Integrata di Trieste, 34128 Trieste, Italy.
  • Mularoni A; Section of Infectious Diseases, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.
  • Mussini C; Department of Health Sciences (DISSAL), University of Genoa, 16126 Genoa, Italy.
  • Oliva A; Infectious Diseases Unit, San Martino Polyclinic Hospital-IRCCS, 16132 Genoa, Italy.
  • Pandolfo A; Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Rogati C; Infectious Diseases ISMETT IRCCS, 90127 Palermo, Italy.
  • Trapani FF; Clinic of Infectious Diseases, University of Modena and Reggio Emilia, 41121 Modena, Italy.
  • Venditti M; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Policlinico Umberto I, 00185 Rome, Italy.
  • Viale P; Infectious Diseases, ASST Lecco Hospital, 23900 Lecco, Italy.
  • Caraffa E; Clinic of Infectious Diseases, University of Modena and Reggio Emilia, 41121 Modena, Italy.
  • Cataldo MA; Department of Medical and Surgical Sciences, "Alma Mater Studiorum", IRCCS S. Orsola Teaching Hospital, University of Bologna, 40126 Bologna, Italy.
  • On Behalf Of The ReCloDi Recurrence Of Clostridioides Difficile Infection Study Group; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Policlinico Umberto I, 00185 Rome, Italy.
J Clin Med ; 10(5)2021 Mar 08.
Article em En | MEDLINE | ID: mdl-33800334
ABSTRACT

BACKGROUND:

Limited and wide-ranging data are available on the recurrent Clostridioides difficile infection (rCDI) incidence rate.

METHODS:

We performed a cohort study with the aim to assess the incidence of and risk factors for rCDI. Adult patients with a first CDI, hospitalized in 15 Italian hospitals, were prospectively included and followed-up for 30 d after the end of antimicrobial treatment for their first CDI. A case-control study was performed to identify risk factors associated with 30-day onset rCDI.

RESULTS:

Three hundred nine patients with a first CDI were included in the study; 32% of the CDI episodes (99/309) were severe/complicated; complete follow-up was available for 288 patients (19 died during the first CDI episode, and 2 were lost during follow-up). At the end of the study, the crude all-cause mortality rate was 10.7% (33 deaths/309 patients). Two hundred seventy-one patients completed the follow-up; rCDI occurred in 21% of patients (56/271) with an incidence rate of 72/10,000 patient-days. Logistic regression analysis identified exposure to cephalosporin as an independent risk factor associated with rCDI (RR 1.7; 95% CI 1.1-2.7, p = 0.03).

CONCLUSION:

Our study confirms the relevance of rCDI in terms of morbidity and mortality and provides a reliable estimation of its incidence.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article